Results 181 to 190 of about 34,670 (250)

Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: <i>Initial In Vivo Proof-of-Concept</i>. [PDF]

Antibiotics (Basel)
Nurmohamed FRHA, Allen KJH, Malo ME, Frank C, van Duvenbode JFFH, van der Wildt B, Poot AJ, Lam MGEH, van Strijp JAG, Nikkels PGJ, Vogely HC, Weinans H, Dadachova E, van der Wal BCH.   +13 more
europepmc   +1 more source

Radionuclide-labeled nanomaterials for tumor therapy: Recent progress and perspectives. [PDF]

Mater Today Bio
Zhen Z, Feng L, Liu H, Chen M, Chen J, Wang J.   +5 more
europepmc   +1 more source

Tritium contamination and hydrological transport in the Shagan River: An isotope hydrology study. [PDF]

PLoS One
Toktaganov T, Mamyrbayeva A, Aidarkhanov А, Aidarkhanova A, Raimkanova A.   +4 more
europepmc   +1 more source

Radiolabeled Vitamins and Nanosystems as Potential Agents in Oncology Theranostics: Developed Approaches and Future Perspectives. [PDF]

J Pers Med
Basirinia G, Comelli A, Alongi P, Ali M, Salvaggio G, Longo C, Di Raimondo D, Tuttolomondo A, Benfante V.   +8 more
europepmc   +1 more source

Framework to calculate ²²⁵Ac, ¹⁷⁷Lu, and ¹⁶¹Tb radiation dose and biological effect in metastatic castration-resistant prostate cancer treatment. [PDF]

Med Phys
Ghaseminejad S, De Sarno D, Bauman G, Lee TY.   +3 more
europepmc   +1 more source

Evaluation of the space disposal of defense nuclear waste, phase 2. Volume 2: Technical Report [PDF]

Conlon, R. J., Edgecombe, D. S., Miller, N. E., Rice, E. E., Yates, K. R.   +4 more
core   +1 more source

Current status of radionuclide therapies in metastatic castration-resistant prostate cancer. [PDF]

Ther Adv Med Oncol
Fei X, Huang RD, Zhou X, Ye SJ, Nan N, Wang KJ, Ma Q.   +6 more
europepmc   +1 more source

The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy. [PDF]

Cancer Immunol Res
Kerr CP, Sheehan-Klenk J, Grudzinski JJ, Adam DP, Nguyen TPT, Ferreira CA, Bates AM, Jin WJ, Kwon O, Olson AP, Lin W, Hyun M, Jagodinsky JC, Powers M, Sriramaneni RN, Clark PA, Shea AG, Comas Rojas H, Choi C, Massey CF, Zangl LM, Pinchuk AN, Aluicio-Sarduy E, Kim K, Engle JW, Hernandez R, Bednarz BP, Weichert JP, Morris ZS.   +28 more
europepmc   +1 more source

Assessment of terrestrial radionuclide exposure and contamination rates within the Mbaitoli area, Nigeria. [PDF]

Sci Rep
Mbonu CC, Agbalagba EO, Mbonu JE, Ben UC, Mbonu IJ, Abdelrahman K, Fnais MS, Gomez-Ortiz D, Agiande D, Eldosouky AM.   +9 more
europepmc   +1 more source

Preclinical Lutetium-177 Intracellular Dosimetry of Target Cancers in Radionuclide Therapy. [PDF]

J Med Phys
Lunev AS, Petrosova KA, Ternovskaya KE, Zakharkina AE, Nigmatulina AI.   +4 more
europepmc   +1 more source